GSK takes lead role in UK personalised medicine programme
May 20, 2011Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine
The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
Pfizer’s cancer drug meets end points in head-to-head study
May 20, 2011Research and Development, Sales and Marketing Pfizer, axitinib, rcc
Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
Stephen Dorrell: Health reforms need wider focus
May 19, 2011Health and Social Care Bill, NHS reforms
The government’s radical reform of the NHS must focus on integrated care and not just GPs, according to the chairman …
Blood cancer charity to kick-start clinical trials
May 19, 2011Research and Development Cancer, blood cancer, clinical trials, leukaemia
A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …
MetMab produces exciting results in lung cancer patients
May 19, 2011Research and Development MetMAb, Roche
Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
Takeda buys Nycomed for $13.6bn
May 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda
Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
Patheon appoints Michael Lytton
May 19, 2011Manufacturing and Production appointment, manufacturing and production
Canadian contract manufacturer Patheon has appointed Michael Lytton as executive VP, corporate development and strategy, and general counsel. He moves …
Digital media – spreading the word on Return on Investment
May 19, 2011Medical Communications, Sales and Marketing ROI, digital marketing
The rise of digital marketing in the pharma sector has brought renewed focus to tracking effectiveness, because digital is seen …
Grunenthal in talks to sell pain drug portfolio
May 19, 2011Sales and Marketing Grunenthal, Stada, chronic pain, pain therapeutics
Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …
TBWA Paling Walters appoints new creative director
May 18, 2011Medical Communications appointment, medical communications
Dick Dunford has joined UK healthcare communications agency TBWA\ Paling Walters as its executive creative director. He has over 20 …
Merck and Roche sign hepatitis C co-promotion deal
May 18, 2011Medical Communications, Sales and Marketing Merck, Roche, hepatitis C
Merck & Co and Roche have signed an agreement that will see them co-promote each other’s hepatitis C drugs in …
Pfizer files lung cancer drug in US and Japan
May 18, 2011Sales and Marketing NSCLC, Pfizer, crizotinib
Pfizer has submitted its oral lung cancer drug crizotinib for regulatory approval in the US and Japan. Crizotinib is an …
Shire makes $750m regenerative medicines acquisition
May 18, 2011Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine
Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …
Mark Dean-Netscher joins Penn Pharma
May 18, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Prime Minister stands by radical NHS shake up
May 17, 2011Health and Social Care Bill, NHS reforms
Prime Minister David Cameron is standing firm on the government’s planned restructuring of the NHS despite mounting opposition. Cameron was …
Lilly accused of anti-competitive practices
May 17, 2011Amylin, Boehringer, diabetes, exenatide, lilly, linagliptin
Amylin Pharmaceuticals is suing Eli Lilly and Company for alleged anticompetitive activity around Lilly’s January agreement with Boehringer Ingelheim to …
Teva plans Japan expansion with Taiyo buy
May 17, 2011Sales and Marketing Taiyo, Teva, generics
Teva is to acquire a majority stake in Taiyo, Japan’s third largest generics company for $460 million in cash. The …
Lonza invests again in Visp high-potency capacity
May 17, 2011Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production
Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …
HIV drug Prezista recalled on TBA contamination
May 17, 2011Manufacturing and Production HIV, Johnson & Johnson, Prezista, manufacturing and production, recalls
Johnson & Johnson has recalled 11,700 bottles of its HIV treatment Prezista after consumer reports of a mouldy smell caused …
Pharma manufacturing news in brief
May 17, 2011Manufacturing and Production manufacturing and production
There are new facilities for Alexion, Biovest and Pharmascience, a production contract for Dalton Pharma Services and progress in Codexis’ …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
